Abstract
A 30 months-old boy with Farber disease developed nystagmus 12 months after hematopoietic stem cell transplantation (HSCT). At 40 months, gait ataxia was evident, and brain MRI showed increased size of pericerebellar sulci and 4th ventricle. EMG showed denervation in the tongue and upper limb muscles, consistent with motor neuron disease. HSCT improves the peripheral manifestations of Farber disease, but may not prevent the progressive neurological deterioration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Torcoletti M, Petaccia A, Pinto RM et al (2014) Farber disease in infancy resembling juvenile idiopathic arthritis: identification of two new mutations and a good early response to allogeneic haematopoietic stem cell transplantation. Rheumatology (Oxford) 53:1533–1534
Yeager AM, Uhas KA, Coles CD et al (2000) Bone marrow transplantation for infantile ceramidase deficiency (Farber disease). Bone Marrow Transplant 26:357–363
Zhou J, Tawk M, Tiziano FD et al (2012) Spinal muscular atrophy associated with progressive myoclonic epilepsy is caused by mutations in ASAH1. Am J Hum Genet 91:5–14
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by: Nicole Wolf
Rights and permissions
About this article
Cite this article
Cappellari, A.M., Torcoletti, M., Triulzi, F. et al. Nervous system involvement in Farber disease. J Inherit Metab Dis 39, 149–150 (2016). https://doi.org/10.1007/s10545-015-9890-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-015-9890-0